Minerva Neurosciences, Inc. Quarterly Operating Income (Loss) in USD from Q1 2013 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: Minerva Neurosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2013 to Q2 2024.
Minerva Neurosciences, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$6.28M, a 38.9% decline year-over-year.
Minerva Neurosciences, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$26.2M, a 30.1% decline year-over-year.
Minerva Neurosciences, Inc. annual Operating Income (Loss) for 2023 was -$23.1M, a 8.37% increase from 2022.
Minerva Neurosciences, Inc. annual Operating Income (Loss) for 2022 was -$25.2M, a 44.4% increase from 2021.
Minerva Neurosciences, Inc. annual Operating Income (Loss) for 2021 was -$45.4M, a 2557% decline from 2020.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2024	-$26.2M	-$6.28M	-$1.76M	-38.9%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-06
Q1 2024	-$24.5M	-$6.68M	-$1.33M	-24.9%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-01
Q4 2023	-$23.1M	-$7.17M	-$2.1M	-41.5%	Oct 1, 2023	Dec 31, 2023	10-K	2024-02-22
Q3 2023	-$21M	-$6.08M	-$872K	-16.7%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-07
Q2 2023	-$20.1M	-$4.52M	+$2.45M	+35.1%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-06
Q1 2023	-$22.6M	-$5.35M	+$2.64M	+33.1%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-01
Q4 2022	-$25.2M	-$5.07M	+$16.3M	+76.3%	Oct 1, 2022	Dec 31, 2022	10-K	2024-02-22
Q3 2022	-$41.5M	-$5.21M	+$2.31M	+30.7%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-07
Q2 2022	-$43.8M	-$6.97M	+$2M	+22.3%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-01
Q1 2022	-$45.8M	-$7.99M	-$482K	-6.42%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-15
Q4 2021	-$45.4M	-$21.4M	-$14.1M	-193%	Oct 1, 2021	Dec 31, 2021	10-K	2023-03-08
Q3 2021	-$31.3M	-$7.52M	+$573K	+7.08%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-09
Q2 2021	-$31.9M	-$8.96M	-$38.5M	-130%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-09
Q1 2021	$6.61M	-$7.51M	+$4.76M	+38.8%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-04
Q4 2020	$1.85M	-$7.3M	+$25.1M	+77.4%	Oct 1, 2020	Dec 31, 2020	10-K	2021-03-08
Q3 2020	-$23.2M	-$8.09M	+$6.19M	+43.4%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-08
Q2 2020	-$29.4M	$29.5M	+$42.4M		Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-02
Q1 2020	-$71.8M	-$12.3M	+$4.04M	+24.8%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-12
Q4 2019	-$75.9M	-$32.4M	-$18.7M	-138%	Oct 1, 2019	Dec 31, 2019	10-K	2021-03-08
Q3 2019	-$57.1M	-$14.3M	-$1.86M	-15%	Jul 1, 2019	Sep 30, 2019	10-K	2021-03-08
Q2 2019	-$55.3M	-$12.9M	+$31K	+0.24%	Apr 1, 2019	Jun 30, 2019	10-K	2021-03-08
Q1 2019	-$55.3M	-$16.3M	-$3.57M	-28%	Jan 1, 2019	Mar 31, 2019	10-K	2021-03-08
Q4 2018	-$51.7M	-$13.6M	-$4.1M	-43%	Oct 1, 2018	Dec 31, 2018	10-K	2020-03-09
Q3 2018	-$47.6M	-$12.4M	-$1.02M	-8.92%	Jul 1, 2018	Sep 30, 2018	10-K	2020-03-09
Q2 2018	-$46.6M	-$12.9M	-$3.19M	-32.7%	Apr 1, 2018	Jun 30, 2018	10-K	2020-03-09
Q1 2018	-$43.4M	-$12.7M	-$2.26M	-21.5%	Jan 1, 2018	Mar 31, 2018	10-K	2020-03-09
Q4 2017	-$41.2M	-$9.53M	-$295K	-3.19%	Oct 1, 2017	Dec 31, 2017	10-K	2019-03-12
Q3 2017	-$40.9M	-$11.4M	-$3.18M	-38.6%	Jul 1, 2017	Sep 30, 2017	10-K	2019-03-12
Q2 2017	-$37.7M	-$9.75M	-$4.78M	-96.3%	Apr 1, 2017	Jun 30, 2017	10-K	2019-03-12
Q1 2017	-$32.9M	-$10.5M	-$2.73M	-35.2%	Jan 1, 2017	Mar 31, 2017	10-K	2019-03-12
Q4 2016	-$30.2M	-$9.24M	-$1.04M	-12.7%	Oct 1, 2016	Dec 31, 2016	10-K	2018-03-12
Q3 2016	-$29.1M	-$8.23M	-$2.53M	-44.3%	Jul 1, 2016	Sep 30, 2016	10-K	2018-03-12
Q2 2016	-$26.6M	-$4.97M	+$1.37M	+21.6%	Apr 1, 2016	Jun 30, 2016	10-K	2018-03-12
Q1 2016	-$28M	-$7.76M	-$1.88M	-32%	Jan 1, 2016	Mar 31, 2016	10-K	2018-03-12
Q4 2015	-$26.1M	-$8.19M	-$748K	-10%	Oct 1, 2015	Dec 31, 2015	10-K	2018-03-12
Q3 2015	-$25.4M	-$5.71M	+$21.4M	+79%	Jul 1, 2015	Sep 30, 2015	10-K	2018-03-12
Q2 2015	-$46.8M	-$6.33M	+$11.3M	+64.1%	Apr 1, 2015	Jun 30, 2015	10-K	2018-03-12
Q1 2015	-$58.1M	-$5.88M	-$3.26M	-124%	Jan 1, 2015	Mar 31, 2015	10-K	2018-03-12
Q4 2014	-$54.9M	-$7.45M	-$5.4M	-264%	Oct 1, 2014	Dec 31, 2014	10-K	2017-03-13
Q3 2014	-$49.5M	-$27.2M	-$26.7M	-5533%	Jul 1, 2014	Sep 30, 2014	10-K	2017-03-13
Q2 2014	-$22.8M	-$17.7M	-$17.3M	-4557%	Apr 1, 2014	Jun 30, 2014	10-K	2017-03-13
Q1 2014	-$5.53M	-$2.62M	-$2.35M	-868%	Jan 1, 2014	Mar 31, 2014	10-K	2017-03-13
Q4 2013	-$3.18M	-$2.04M			Oct 1, 2013	Dec 31, 2013	10-K	2015-03-26
Q3 2013		-$482K			Jul 1, 2013	Sep 30, 2013	10-K	2015-03-26
Q2 2013		-$379K			Apr 1, 2013	Jun 30, 2013	10-K	2015-03-26
Q1 2013		-$271K			Jan 1, 2013	Mar 31, 2013	10-K	2015-03-26

* An asterisk sign (*) next to the value indicates that the value is likely invalid.